UBS Group AG

Holdings History for Vaxcyte, Inc. - COMMON STOCK (PCVX)

Symbol: PCVX on Nasdaq
Investment type: Equity / COMMON STOCK

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	+0%	$50,458,382	1,093,593	+246,020	+29%	$46.14	Q4 2025
30 Sep 2025	0.01%	-0%	$30,529,579	847,573	-533,280	-39%	$36.02	Q3 2025
30 Jun 2025	0.01%	+0%	$44,891,531	1,380,853	+300,457	+28%	$32.51	Q2 2025
31 Mar 2025	0.01%	+0%	$40,795,753	1,080,396	+343,835		$37.76	Q1 2025
31 Dec 2024	0.01%	+0.01%	$60,294,884	736,561	+624,988	+560%	$81.86	Q4 2024
30 Sep 2024	0%	+0%	$12,749,446	111,573	+15,897	+17%	$114.27	Q3 2024
30 Jun 2024	0%	-0%	$7,224,495	95,676	-80,402	-46%	$75.51	Q2 2024
31 Mar 2024	0%	+0%	$12,027,889	176,078	+10,044	+6%	$68.31	Q1 2024
31 Dec 2023	0%	+0%	$10,426,936	166,034	+91,729	+123%	$62.80	Q4 2023
30 Sep 2023	0%	+0%	$3,788,069	74,305	+28,483	+62%	$50.98	Q3 2023
30 Jun 2023	0%	+0%	$2,288,350	45,822	+45,478	+13220%	$49.94	Q2 2023
31 Mar 2023	0%	-0%	$12,893	344	-122,376	-100%	$37.48	Q1 2023
31 Dec 2022	0%	+0%	$5,884,424	122,720	+122,645	+163527%	$47.95	Q4 2022
30 Sep 2022	0%	-0%	$2,000	75	-23,498	-100%	$26.67	Q3 2022
30 Jun 2022	0%	-0%	$513,000	23,573	-36,814	-61%	$21.76	Q2 2022
31 Mar 2022	0%	+0%	$1,458,000	60,387	+15,152	+33%	$24.14	Q1 2022
31 Dec 2021	0%	-0%	$1,076,000	45,235	-76,529	-63%	$23.79	Q4 2021
30 Sep 2021		0%	$1,000	23	0		$43.48 ^*	Q3 2021
30 Sep 2021	0%	+0%	$3,090,000	121,764	+13,861	+13%	$25.38	Q3 2021
30 Jun 2021	0%	-0%	$2,429,000	107,903	-7,547	-6.5%	$22.51	Q2 2021
31 Mar 2021	0%	+0%	$2,280,000	115,450	+47,284	+69%	$19.75	Q1 2021
31 Dec 2020	0%	+0%	$1,811,000	68,166	+67,446	+9368%	$26.57	Q4 2020
30 Sep 2020	0%	+0%	$36,000	720	+720	NEW	$50.00	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.